Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: Retrospective cohort analysis

BMJ (Online)

Volumn 340, Issue 7746, 2010, Pages 581-

  Punglia, Rinaa S ^a   Saito, Akiko M ^a,b   Neville, Bridget A ^a   Earle, Craig C ^a,c   Weeks, Jane C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICARE; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 77949388214     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c845     Document Type: Article

References (35)

1. Jack RH, Davies EA, Robinson D, Sainsbury R, Moller H. Radiotherapy waiting times for women with breast cancer: a population-based cohort study. BMC Cancer 2007;7:71.
2. Mikeljevic JS, Haward R, Johnston C, Crellin A, Dodwell D, Jones A, et al. Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery. Br J Cancer 2004;90:1343-8.
3. Johnston GM, MacGarvie VL, Elliott D, Dewar RA, MacIntyre MM, Nolan MC. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000. Clin Invest Med 2004;27:142-56.
4. Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J RadiatOncol Biol Phys 1994;30:221-8.
5. Dodwell D, Crellin A. Waiting for radiotherapy. BMJ 2006;332:107-9.
6. Schäfer C, Nelson K, Herbst M.Waiting for radiotherapy. Strahlentherapie und Onkologie 2005;181:9-19.
7. Lim KSH, Vinod SK, Bull C, O'Brien P, Kenny L. Prioritization of radiotherapy in Australia and New Zealand. Australas Radiol 2005;49:485-8.
8. Mackillop WJ. Killing time: the consequences of delays in radiotherapy. Radiother Oncol 2007;84:1-4.
9. Buchholz TA. Radiation therapy for early-stage breast cancer after breast-conserving surgery.N Engl J Med 2009;360:63-70.
10. Cefaro GA, Genovesi D, Marchese R, Di Tommaso M, Di Febo F, Ballone E, et al. The effect of delaying adjuvant radiation treatment after conservative surgery for early breast cancer. Breast J 2007;13:575-80.
11. Froud PJ, Mates D, Jackson JS, Phillips N, Andersen S, Jackson SM, et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 2000;46:363-72.
12. Livi L, Borghesi S, Saieva C, Meattini I, Rampini A, Petrucci A, et al. Radiotherapy timing in 4,820 patients with breast cancer: University of Florence experience. Int J Radiat Oncol Biol Phys 2009;73:365-9.
13. Olivotto IA, Lesperance ML, Truong PT, Nichol A, Berrang T, Tyldesley S, et al. Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy. J ClinOncol 2009;27:16-23.
14. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003;21:555-63.
15. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol 2008;87:3-16.
16. Hebert-Croteau N, Freeman CR, Latreille J, Rivard M, Brisson J. A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat 2004;88:187-96.
17. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
18. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-48.
19. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40(suppl 8):IV-3-18S.
20. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
21. Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006;98:681-90.
22. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
24. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-67.
25. American Hospital Association (AHA). Hospital statistics. AHA, 2000.
26. Whelan TJ. Use of conventional radiation therapy as part of breast-conserving treatment. J Clin Oncol 2005;23:1718-25.
27. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998;19:17-34.
28. Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L,Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 2001;91(suppl 8):1679-87S.
29. Gage I, Recht A, Gelman R, Nixon AJ, Silver B, Bornstein BA, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:245-51.
30. Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001;19:2254-62.
31. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 1999;86:628-37.
32. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996;88:716-26.
33. Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 2005;23:1934-40.
34. Hillner BE, Penberthy L, Desch CE, McDonald MK, Smith TJ, Retchin SM. Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat 1996;40:75-86.
35. Gilligan MA, Kneusel RT, Hoffmann RG, Greer AL, Nattinger AB. Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 2002;40:181-9.